Ubiquitination and Degradation of CFTR by the E3 Ubiquitin Ligase MARCH2 through Its Association with Adaptor Proteins CAL and STX6

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Cheng, Jie ^a   Guggino, William ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BAFILOMYCIN A1; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR ASSOCIATED LIGAND; MARCH2 PROTEIN; SMALL INTERFERING RNA; SYNTAXIN 6; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; GENE SILENCING; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYSOSOME; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

CARRIER PROTEINS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GOLGI APPARATUS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYSOSOMES; MACROLIDES; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MUTATION; PROTEIN BINDING; PROTEOLYSIS; QA-SNARE PROTEINS; RNA INTERFERENCE; UBIQUITINATION;

EID: 84879260385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068001     Document Type: Article

References (50)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080. doi:10.1126/science.2570460. PubMed: 2570460.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073. doi:10.1126/science.2475911. PubMed: 2475911.
3. Pilewski JM, Frizzell RA, (1999) Role of CFTR in airway disease. Physiol Rev 79: S215-S255. PubMed: 9922383.
4. Ye S, Cihil K, Stolz DB, Pilewski JM, Stanton BA, et al. (2010) c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells. J Biol Chem 285: 27008-27018. doi:10.1074/jbc.M110.139881. PubMed: 20525683.
5. Fu L, Rab A, Tang LP, Rowe SM, Bebok Z, et al. (2012) Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator. Biochem J 441: 633-643. doi:10.1042/BJ20111566. PubMed: 21995445.
6. Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM, (2001) The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 3: 100-105. doi:10.1038/35070137. PubMed: 11146634.
7. Younger JM, Chen L, Ren HY, Rosser MF, Turnbull EL, et al. (2006) Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126: 571-582. doi:10.1016/j.cell.2006.06.041. PubMed: 16901789.
8. Matsumura Y, David LL, Skach WR, (2011) Role of Hsc70 binding cycle in CFTR folding and endoplasmic reticulum-associated degradation. Mol Biol Cell 22: 2797-2809. doi:10.1091/mbc.E11-02-0137. PubMed: 21697503.
9. Bomberger JM, Barnaby RL, Stanton BA, (2009) The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells. J Biol Chem 284: 18778-18789. doi:10.1074/jbc.M109.001685. PubMed: 19398555.
10. Schmidt BZ, Watts RJ, Aridor M, Frizzell RA, (2009) Cysteine string protein promotes proteasomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by increasing its interaction with the C terminus of Hsp70-interacting protein and promoting CFTR ubiquitylation. J Biol Chem 284: 4168-4178. PubMed: 19098309.
11. Sun F, Zhang R, Gong X, Geng X, Drain PF, et al. (2006) Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J Biol Chem 281: 36856-36863. doi:10.1074/jbc.M607085200. PubMed: 16954204.
12. Okiyoneda T, Barrière H, Bagdány M, Rabeh WM, Du K, et al. (2010) Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329: 805-810. doi:10.1126/science.1191542. PubMed: 20595578.
13. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, et al. (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83: 129-135. doi:10.1016/0092-8674(95)90241-4. PubMed: 7553864.
14. Ward CL, Omura S, Kopito RR, (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83: 121-127. doi:10.1016/0092-8674(95)90240-6. PubMed: 7553863.
15. Sharma M, Pampinella F, Nemes C, Benharouga M, So J, et al. (2004) Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol 164: 923-933. doi:10.1083/jcb.200312018. PubMed: 15007060.
16. Morito D, Hirao K, Oda Y, Hosokawa N, Tokunaga F, et al. (2008) Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. Mol Biol Cell 19: 1328-1336. doi:10.1091/mbc.E07-06-0601. PubMed: 18216283.
17. Ballar P, Ors AU, Yang H, Fang S, (2010) Differential regulation of CFTRDeltaF508 degradation by ubiquitin ligases gp78 and Hrd1. Int J Biochem Cell Biol 42: 167-173. doi:10.1016/j.biocel.2009.10.005. PubMed: 19828134.
18. Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, et al. (2002) A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 277: 3520-3529. doi:10.1074/jbc.M110177200. PubMed: 11707463.
19. Cheng J, Wang H, Guggino WB, (2004) Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL. J Biol Chem 279: 1892-1898. doi:10.1074/jbc.M308640200. PubMed: 14570915.
20. Wolde M, Fellows A, Cheng J, Kivenson A, Coutermarsh B, et al. (2007) Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. J Biol Chem 282: 8099-8109. doi:10.1074/jbc.M611049200. PubMed: 17158866.
21. Cheng J, Cebotaru V, Cebotaru L, Guggino WB, (2010) Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 21: 1178-1187. doi:10.1091/mbc.E09-03-0229. PubMed: 20130090.
22. Cushing PR, Vouilleme L, Pellegrini M, Boisguerin P, Madden DR, (2010) A stabilizing influence: CAL PDZ inhibition extends the half-life of DeltaF508-CFTR. Angew Chem Int Ed Engl 49: 9907-9911. doi:10.1002/anie.201005585. PubMed: 21105033.
23. Amacher JF, Cushing PR, Weiner JA, Madden DR, (2011) Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor. Acta Crystallogr Sect F Struct Biol Cryst Commun 67: 600-603. doi:10.1107/S1744309111009985.
24. Nakamura N, Fukuda H, Kato A, Hirose S, (2005) MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking. Mol Biol Cell 16: 1696-1710. doi:10.1091/mbc.E04-03-0216. PubMed: 15689499.
25. Fukuda H, Nakamura N, Hirose S, (2006) MARCH-III Is a novel component of endosomes with properties similar to those of MARCH-II. J Biochem 139: 137-145. doi:10.1093/jb/mvj012. PubMed: 16428329.
26. Lehner PJ, Hoer S, Dodd R, Duncan LM, (2005) Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207: 112-125. doi:10.1111/j.0105-2896.2005.00314.x. PubMed: 16181331.
27. Boname JM, Stevenson PG, (2001) MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15: 627-636. doi:10.1016/S1074-7613(01)00213-8. PubMed: 11672544.
28. Coscoy L, Sanchez DJ, Ganem D, (2001) A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J Cell Biol 155: 1265-1273. doi:10.1083/jcb.200111010. PubMed: 11756476.
29. Nathan JA, Lehner PJ, (2009) The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp Cell Res 315: 1593-1600. doi:10.1016/j.yexcr.2008.10.026. PubMed: 19013150.
30. Bartee E, Mansouri M, Hovey Nerenberg BT, Gouveia K, Früh K, (2004) Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78: 1109-1120. doi:10.1128/JVI.78.3.1109-1120.2004. PubMed: 14722266.
31. De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, et al. (2008) MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci U S A 105: 3491-3496. doi:10.1073/pnas.0708874105. PubMed: 18305173.
32. Lapaque N, Jahnke M, Trowsdale J, Kelly AP, (2009) The HLA-DRalpha chain is modified by polyubiquitination. J Biol Chem 284: 7007-7016. PubMed: 19117940.
33. Corcoran K, Jabbour M, Bhagwandin C, Deymier MJ, Theisen DL, et al. (2011) Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). J Biol Chem 286: 37168-37180. doi:10.1074/jbc.M110.204040. PubMed: 21896490.
34. Han SO, Xiao K, Kim J, Wu JH, Wisler JW, et al. (2012) MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors. J Cell Biol 199: 817-830. doi:10.1083/jcb.201208192. PubMed: 23166351.
35. Treier M, Staszewski LM, Bohmann D, (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798. doi:10.1016/S0092-8674(94)90502-9. PubMed: 8087846.
36. Wang S, Raab RW, Schatz PJ, Guggino WB, Li M, (1998) Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett 427: 103-108. doi:10.1016/S0014-5793(98)00402-5. PubMed: 9613608.
37. Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, et al. (1998) A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci U S A 95: 8496-8501. doi:10.1073/pnas.95.15.8496. PubMed: 9671706.
38. Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, et al. (1998) An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 273: 19797-19801. doi:10.1074/jbc.273.31.19797. PubMed: 9677412.
39. Ito H, Iwamoto I, Morishita R, Nozawa Y, Asano T, et al. (2006) Identification of a PDZ protein, PIST, as a binding partner for Rho effector Rhotekin: biochemical and cell-biological characterization of Rhotekin-PIST interaction. Biochem J 397: 389-398. doi:10.1042/BJ20052015. PubMed: 16646955.
40. Charest A, Lane K, McMahon K, Housman DE, (2001) Association of a novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor) protein syntaxin 6. J Biol Chem 276: 29456-29465. doi:10.1074/jbc.M104137200. PubMed: 11384996.
41. Cheng J, Wang H, Guggino WB, (2005) Regulation of cystic fibrosis transmembrane regulator trafficking and protein expression by a Rho family small GTPase TC10. J Biol Chem 280: 3731-3739. PubMed: 15546864.
42. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834. doi:10.1016/0092-8674(90)90148-8. PubMed: 1699669.
43. Cutting GR, (1993) Spectrum of mutations in cystic fibrosis. J Bioenerg Biomembr 25: 7-10. doi:10.1007/BF00768062. PubMed: 7680032.
44. Welsh MJ, Smith AE, (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73: 1251-1254. doi:10.1016/0092-8674(93)90353-R. PubMed: 7686820.
45. Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, et al. (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 115: 2564-2571. doi:10.1172/JCI24898. PubMed: 16127463.
46. Van Goor F, Straley KS, Cao D, González J, Hadida S, et al. (2006) Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol Lung Cell Mol Physiol 290: L1117-L1130. doi:10.1152/ajplung.00169.2005. PubMed: 16443646.
47. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, et al. (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A 108: 18843-18848. doi:10.1073/pnas.1105787108. PubMed: 21976485.
48. Robert R, Carlile GW, Liao J, Balghi H, Lesimple P, et al. (2010) Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine. Mol Pharmacol 77: 922-930. doi:10.1124/mol.109.062679. PubMed: 20200141.
49. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, et al. (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365: 1663-1672. doi:10.1056/NEJMoa1105185. PubMed: 22047557.
50. Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, et al. (2012) Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax 67: 12-18. doi:10.1136/thoraxjnl-2011-200393. PubMed: 21825083.